SELECT-LIFE (SELECT Follow-up Study to Evaluate Long-term Impact oF Anti-obEsity Medication)

Status: Recruiting
Location: See all (38) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Participants are being asked to participate in SELECT-LIFE study because participants take part in the SELECT trial. SELECT-LIFE study is a survey-based study that will start when the SELECT trial ends. SELECT-LIFE looks at the long-term effects of participants taking part in the SELECT trial including the trial medicine participants have been taking. When the SELECT trial ends, participants will no longer get the medicine participants got in the study, even if participants decide to take part in the SELECT-LIFE study. Participants will not get any specific treatment or medicine as part of the SELECT-LIFE study, and participants will be treated as participants normally would by their own doctor. The SELECT-LIFE study will last for up to 10 years after SELECT trial ends, and participants will be asked to fill in a questionnaire about their health every 6 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Healthy Volunteers: f
View:

• Randomized into the SELECT clinical trial (EX9536-4388) and has not withdrawn consent, regardless of level of participation, dose achieved or treatment discontinuation.

• Signed SELECT-LIFE consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).

Locations
United States
New Jersey
Master Centre for USA
RECRUITING
Plainsboro
Other Locations
Algeria
Master Centre for Algeria
RECRUITING
Algiers
Argentina
Master Centre for Argentina
RECRUITING
Prov. De Buenos Aires
Australia
Master Centre for Australia
RECRUITING
North Sydney
Brazil
AngioCor Blumenau
ENROLLING_BY_INVITATION
Blumenau
Hospital do Coração do Brasil
ENROLLING_BY_INVITATION
Brasília
Instituto de Pesquisa Clínica de Campinas
ENROLLING_BY_INVITATION
Campinas
Núcleo de Pesquisa Clínica S/S
ENROLLING_BY_INVITATION
Curitiba
Hospital São Vicente de Paulo
ENROLLING_BY_INVITATION
Passo Fundo
Instituto Brasil de Pesquisa Clinica
ENROLLING_BY_INVITATION
Rio De Janeiro
Cárdio Pulmonar da Bahia
ENROLLING_BY_INVITATION
Salvador
CIP Centro Integrado de Pesquisas do Hospital de Base
ENROLLING_BY_INVITATION
São José Do Rio Preto
Master Centre for Brazil
RECRUITING
Säo Paulo
CPCLIN - Centro de Pesquisas Clínicas
ENROLLING_BY_INVITATION
São Paulo
CPQuali Pesquisa Clínica Ltda
RECRUITING
São Paulo
Departamento de Gastroenterologia - HCFMUSP
ENROLLING_BY_INVITATION
São Paulo
Instituto Dante Pazzanese de Cardiologia
ENROLLING_BY_INVITATION
São Paulo
Instituto do Coração - HCFMUSP
ENROLLING_BY_INVITATION
São Paulo
Eurolatino Medical Research Center
ENROLLING_BY_INVITATION
Uberlândia
Canada
Master Centre for Canada
RECRUITING
Mississauga
Croatia
Novo Nordisk Croatia Ltd.
RECRUITING
Zagreb
Denmark
Master Centre for Denmark
RECRUITING
Copenhagen S
Finland
Master Centre for Finland
RECRUITING
Espoo
Germany
Master Centre for Germany PMS
ACTIVE_NOT_RECRUITING
Mainz
Greece
Master Centre for Greece
RECRUITING
Vouliagment
India
Master centre for India
ENROLLING_BY_INVITATION
Bangalore
Ireland
Master Centre for Ireland
ENROLLING_BY_INVITATION
Dublin
Italy
Master Centre for Italy
RECRUITING
Rome
Japan
Master Centre for Japan
ENROLLING_BY_INVITATION
Tokyo
Latvia
MAster Centre for Latvia
ENROLLING_BY_INVITATION
Marupes
Malaysia
Master Centre for Malaysia
RECRUITING
Selangor Darul Ehsan
Netherlands
Master Centre Netherlands
ENROLLING_BY_INVITATION
Alphen Aan Den Rijn
Norway
Master Centre for Norway
ENROLLING_BY_INVITATION
Rud
South Africa
Master Centre for South Africa
RECRUITING
Sandton
Sweden
Master Centre for Sweden
ENROLLING_BY_INVITATION
Malmo
Taiwan
Master Centre for Tawain
RECRUITING
Taipei
Thailand
Master Centre for Thailand
RECRUITING
Bangkok
United Kingdom
Master Centre for United Kingdom
RECRUITING
Gatwick
Contact Information
Primary
Novo Nordisk
clinicaltrials@novonordisk.com
(+1) 866-867-7178
Time Frame
Start Date: 2023-09-01
Estimated Completion Date: 2033-11-30
Participants
Target number of participants: 3400
Treatments
Questionnaire survey
Participants of the SELECT trial (EX9536-4388 ) are invited to transition to SELECT-LIFE (follow-up study) when SELECT ends.
Related Therapeutic Areas
Sponsors
Leads: Novo Nordisk A/S

This content was sourced from clinicaltrials.gov